Novogene and Pacific Biosciences to Jointly Develop and Co-Market Novel Applications Based on Sequel Platform
SAN DIEGO and MENLO PARK, Calif., July 18, 2017 (GLOBE NEWSWIRE) — Novogene, a leading global provider of genomic services and solutions, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the leader in long-read sequencing, have agreed to jointly develop and promote novel applications based on the PacBio® Sequel® System. New applications developed under this agreement... Read more